Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 5 July 2006. doi:10.1136/jcp.2005.034223
Journal of Clinical Pathology 2007;60:622-626
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

ORIGINAL ARTICLE

Low meprin {alpha} expression differentiates primary ovarian mucinous carcinoma from gastrointestinal cancers that commonly metastasise to the ovaries

Viola A Heinzelmann-Schwarz1, Richard A Scolyer2, James P Scurry3, Alison N Smith1, Margaret Gardiner-Garden1, Andrew V Biankin1, Sally Baron-Hay4, Carolyn Scott4, Robyn L Ward5, Daniel Fink6, Neville F Hacker7, Robert L Sutherland1 and Philippa M O’Brien1

1 Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia
2 Department of Anatomical Pathology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
3 South Eastern Area Laboratory Service, Prince of Wales Hospital, Randwick, New South Wales, Australia
4 Kolling Institute of Medical Research, Royal North Shore Hospital, St Leonards, New South Wales, Australia
5 Department of Medical Oncology, St Vincent’s Hospital, Darlinghurst, New South Wales, Australia
6 Division of Gynecology, University Hospital Zurich, Zurich, Switzerland
7 Gynaecological Cancer Centre, Royal Hospital for Women, Randwick, New South Wales, Australia

Correspondence to:
Correspondence to:
Dr P M O’Brien
Cancer Research Program, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, NSW 2010, Australia; p.obrien{at}garvan.org.au

Background: Currently, no specific immunohistochemical markers are available to differentiate primary mucinous epithelial ovarian cancer (MOC) from adenocarcinomas originating at other sites that have metastasised to the ovary, which may have an impact on patient management and prognosis.

Aim: To investigate the expression of two intestinal markers, galectin 4 and meprin {alpha}, in mucinous carcinomas of the ovary and gastrointestinal tract.

Methods: Using immunohistochemical analysis, the expression of galectin 4 and meprin {alpha} was investigated in 10 MOCs and in 38 mucinous adenocarcinomas of colon, pancreas, stomach and appendix, the most common sites of origin of ovarian metastases.

Results: Total cytoplasmic galectin 4 expression was relatively consistent between the different carcinomas. Membranous meprin {alpha} expression was significantly lower in MOCs compared with gastrointestinal carcinomas. Moreover, meprin {alpha} expression showed greater discrimination between the ovarian and gastrointestinal carcinomas than the cytokeratins CK7 and CK20, the current standard immunohistochemical markers used to determine the tissue origin of mucinous carcinomas involving the ovaries.

Conclusions: Meprin {alpha} is a useful additional marker in differentiating primary from secondary mucinous adenocarcinomas of the ovary.

Abbreviations: MOC, mucinous epithelial ovarian cancer


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs